CIK 0000944809
- Accelerated filer
OPKO HEALTH, INC.
Sign in to watch- Ticker
- OPK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 752402409
- Phone
- +1 305-575-4181
- Business address
- 4400 BISCAYNE BLVD., MIAMI, FL, 33137
- Former names
- EXEGENICS INC, eXegenics Inc, CYTOCLONAL PHARMACEUTICS INC /DE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,577
- in 1 filing
Net −$24,577. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-05 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +27,059 | $3.94 | $107K | 192,072,753 |
| 2021-03-05 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +200 | $3.95 | $789 | 192,072,953 |
| 2021-03-05 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +11,100 | $3.95 | $44K | 192,084,053 |
| 2021-03-05 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +40,572 | $3.95 | $160K | 192,124,625 |
| 2021-03-05 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +17,069 | $3.96 | $68K | 192,141,694 |
| 2021-03-05 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +8,800 | $3.97 | $35K | 192,150,494 |
| 2021-03-05 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +21,200 | $3.97 | $84K | 192,171,694 |
| 2021-03-01 | Lachman Prem A Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2021-02-19 | Cohen Jon R SVP OPKO; Exec Chairman BRLI | Grant or award · Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2021-02-19 | Logal Adam Sr. Vice President, CFO | Grant or award · Stock Option (Right to Buy) | +350,000 | 350,000 | ||
| 2021-02-19 | Rubin Steven D Executive VP-Administration | Grant or award · Stock Option (Right to Buy) | +350,000 | 350,000 | ||
| 2021-02-19 | HSIAO JANE PH D Vice Chairman & CTO | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2021-02-19 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +8,700 | $4.71 | $41K | 191,380,394 |
| 2021-02-19 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +3,496 | $4.72 | $16K | 191,383,890 |
| 2021-02-19 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +24,204 | $4.72 | $114K | 191,408,094 |
| 2021-02-19 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +1,000 | $4.73 | $5K | 191,409,094 |
| 2021-02-19 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +17,589 | $4.73 | $83K | 191,426,683 |
| 2021-02-19 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +10,204 | $4.74 | $48K | 191,436,887 |
| 2021-02-19 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +73,207 | $4.74 | $347K | 191,510,094 |
| 2021-02-19 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +1,320 | $4.75 | $6K | 191,511,414 |
Page 32 of 33 · 653 trades